NASDAQ / LIVE COMPANY INTELLIGENCE

VSee Health, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERVSEE
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / VSEE COVERAGE

What’s moving VSee Health, Inc. now

Current reporting with the operating signal separated from the noise.

01
VSee Health, Inc. Announces Postponement of Annual Meeting of Stockholders Until December 30, 2025

VSee Health, Inc. Announces Postponement of Annual Meeting of Stockholders Until December 30, 2025

Investors are testing whether VSee Health, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
02
VSee Health, Inc. Regains Compliance with Nasdaq Stockholders' Equity Requirement

VSee Health, Inc. Regains Compliance with Nasdaq Stockholders' Equity Requirement

Investors are testing whether VSee Health, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
03
VSee Health, Inc. Announces Pricing of $6.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor

VSee Health, Inc. Announces Pricing of $6.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor

The story matters when it changes VSee Health, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
VSEE Health, Inc. Delivers Robust Q3 2025 Revenue Growth Amid Telehealth Expansion: Total Revenues Reach $3.98 Million, Up 19% Year-Over-Year

VSEE Health, Inc. Delivers Robust Q3 2025 Revenue Growth Amid Telehealth Expansion: Total Revenues Reach $3.98 Million, Up 19% Year-Over-Year

Investors are testing whether VSee Health, Inc.’s operating performance supports its strategy and valuation.

Watch next: official volume, pricing, inventory and segment margin.
05
VSee Health, Inc. Receives Nasdaq Notice on Delayed Form 10-Q Filing

VSee Health, Inc. Receives Nasdaq Notice on Delayed Form 10-Q Filing

The story matters when it changes VSee Health, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
06
VSee Health, Inc. (VSEE) Secures $340K Contract to Develop AI-Powered EHR and Virtual Care Platform

VSee Health, Inc. (VSEE) Secures $340K Contract to Develop AI-Powered EHR and Virtual Care Platform

The development tests whether VSee Health, Inc. can turn product investment into adoption, revenue and durable advantage.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest VSEE filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-15 · Period 2026-03-31SEC ↗10-Q/AQuarterly financial reportFiled 2025-11-20 · Period 2025-06-30SEC ↗10-KAnnual financial reportFiled 2026-03-31 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-31 · Period 2026-06-30SEC ↗8-KMaterial company eventFiled 2026-07-24 · Period 2026-07-21SEC ↗8-KMaterial company eventFiled 2026-07-10 · Period 2026-07-06SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-07-20 · Period 2026-08-25SEC ↗PRE 14AOfficial SEC filingFiled 2026-07-10 · Period 2026-08-25SEC ↗
EARNINGS / QUARTERLY TRACKER

VSee Health, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.